Multistate Salmonella Outbreak: Cucumber Products Recalled, 26 People Infected
Multiple cucumber products sold in several states are being recalled because of potential salmonella contamination amid an ongoing multistate outbreak.
Maryland-based The Coastal Companies is withdrawing 17 products containing cucumbers from the market, including salsas and salads, according to a May 27 recall
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
5 hours ago
- Business Insider
AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI
Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca's (AZN) IMFINZI in combination with standard-of-care FLOT chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival, EFS, versus chemotherapy alone. Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction, GEJ, cancers. In a planned interim analysis, patients treated with the IMFINZI-based perioperative regimen showed a 29% reduction in the risk of disease progression, recurrence or death versus chemotherapy alone. Estimated median EFS was not yet reached for the IMFINZI arm versus 32.8 months for the comparator arm. For the secondary endpoint of overall survival, a strong trend was observed in favor of the IMFINZI-based perioperative regimen. The trial will continue to follow OS, which will be formally assessed at the final analysis. Confident Investing Starts Here:
Business Insider
5 hours ago
- Business Insider
Guardant Health presented results of largest study on ctDNA in colon cancer
Guardant Health (GH) presented results of the largest study to date evaluating circulating tumor DNA, ctDNA, in colon cancer prior to chemotherapy, demonstrating the ability of the Guardant Reveal test to stratify the risk of disease recurrence and overall survival, and thus inform treatment decisions after surgery. Data from the phase III trial of FOLFOX-based adjuvant chemotherapy involving over 2,000 patients with stage III colon cancer with median follow-up of 6.1 years were presented at the 2025 American Society for Clinical Oncology Annual Meeting. Results demonstrated that circulating tumor DNA detected in the bloodstream after cancer surgery and prior to the start of adjuvant therapy, using the Guardant Reveal test, is a strong predictor of the risk of disease recurrence and poorer survival, and suggest the potential for ctDNA testing to improve decision-making at a critical time point for post-operative chemotherapy. Specifically: Among patients with post-surgical ctDNA detected, 62.6% had the cancer return within 3 years, despite having had adjuvant chemotherapy, while only 15.4% of patients with undetectable ctDNA recurred in the same period. The level of ctDNA, or tumor fraction, showed promise in identifying individuals who are less likely to clear residual disease with adjuvant treatment.
CBS News
5 hours ago
- CBS News
Maryland community rallies to support family of fallen Baltimore firefighter
The mother of a fallen Baltimore firefighter said her son "loved helping everybody." In return, the community gave back to the family of Lt. Mark Dranbauer, who died on May 16 after suffering a medical emergency days earlier while battling a fire. A fundraiser, hosted at Jimmy's Famous Seafood on Sunday, was expected to raise $15,000 to $20,000 for Dranbauer's family. He left behind a 5-year-old son who recently graduated from kindergarten, with firefighters attending the ceremony. "A proper sendoff for him so they can be smiling, and remember in a positive fashion, not just today, but moving forward," said John Minadakis, co-owner of Jimmy's Famous Seafood. Several firefighters, as well as the Punishers LEMC Maryland motorcycle group, with whom Dranbauer rode, shared stories and memories. Tickets to the event included unlimited drinks and a buffet crafted by the chefs at Jimmy's Famous Seafood. There was also a DJ, speeches, games, auctions, celebrity appearances, and more. "It just goes to show how many people cared about Mark and the impact he had," said Robin Dranbauer, Lt. Mark Dranbauer's mother. Saving lives all the way through On May 12, Lt. Dranbauer, 44, was approximately 30 to 40 feet off the ground when he fell backward down a ladder. He remained on the aerial ladder, where he was helped off and taken to a hospital. He was pronounced dead four days later, and with his organ donations, he is expected to save 70 lives, according to medical officials. Lt. Dranbauer served with the Baltimore City Fire Department for 23 years. "He just loved helping everybody," Robin Dranbauer said. Born to be a firefighter Robin Dranbauer told WJZ that Lt. Dranbauer was raised in a firefighting family. His mother and father volunteered for local fire departments. At first, Lt. Dranbauer's family didn't know he was interested in following in his parents' footsteps. "We used to take Mark to the firehouse with us all the time," Robin Dranbauer said. Lt. Dranbauer volunteered as soon as he was allowed, and his parents were along for that first ride. Robin Dranbauer said her son quickly became a leader. "He mentored me on many because I would call him and say, 'I'm not sure I treated this patient right,' and we would talk about it all the time," Robin Dranbauer said. Keeping Lt. Dranbauer's memory alive Lt. Dranbauer's family says they will continue living for their fallen hero, including his mother, who still volunteers with her local firehouse. Her first call reminded her of her son, who worked for Engine Co. 5. "I went down Tuesday to the volunteer firehouse, and my first call was an engine call, so I was like, 'Mark, you're here'…I ride the medic most of all, so I'm going to keep going with that," Robin Dranbauer said.
